Comparison between Admach Systems IPO and Bio Medica Laboratories IPO.
Admach Systems IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Bio Medica Laboratories IPO is a SME Bookbuilding proposed to list at NSE SME.
| Admach Systems IPO | Bio Medica Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aftertrade Broking Pvt.Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Aftertrade Broking Pvt.Ltd. | Prabhat Financial Services Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Admach Systems IPO is up to ₹40.47 Cr whereas the issue size of the Bio Medica Laboratories IPO is up to ₹49.80 Cr. The final issue price of Admach Systems IPO is ₹239.00 per share and of Bio Medica Laboratories IPO is ₹139.00 per share.
| Admach Systems IPO | Bio Medica Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹227.00 per share | ₹132.00 per share |
| Issue Price (Upper) | ₹239.00 per share | ₹139.00 per share |
| Issue Price (Final) | ₹239.00 per share | ₹139.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1000 shares |
| Fresh Issue Size | 16,93,200 shares | 32,06,000 shares |
| Fresh Issue Size (Amount) | up to ₹40.47 Cr | up to ₹44.56 Cr |
| OFS Issue Size | 0 shares | 3,77,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹5.24 Cr |
| Issue Size Total | 16,93,200 shares | 35,83,000 shares |
| Issue Size Total (Amount) | up to ₹40.47 Cr | up to ₹49.80 Cr |
Admach Systems IPO opens on Dec 23, 2025, while Bio Medica Laboratories IPO opens on May 21, 2026. The closing date of Admach Systems IPO and Bio Medica Laboratories IPO is Dec 26, 2025, and May 25, 2026, respectively.
| Admach Systems IPO | Bio Medica Laboratories IPO | |
|---|---|---|
| Anchor Bid Date | Dec 22, 2025 | |
| Issue Open | Dec 23, 2025 | May 21, 2026 |
| Issue Close | Dec 26, 2025 | May 25, 2026 |
| Basis Of Allotment (Tentative) | Dec 29, 2025 | May 26, 2026 |
| Initiation of Refunds (Tentative) | Dec 30, 2025 | May 27, 2026 |
| Credit of Share (Tentative) | Dec 30, 2025 | May 27, 2026 |
| Listing date (Tentative) | Dec 31, 2025 | May 29, 2026 |
| Anchor Lockin End date 1 | Jan 30, 2026 | |
| Anchor Lockin End date 2 | Mar 31, 2026 |
Admach Systems IPO P/E ratio is 19.56, as compared to Bio Medica Laboratories IPO P/E ratio of 13.03.
| Admach Systems IPO | Bio Medica Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 71.87 | 96.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.95 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.56 | 13.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹161.87 Cr. | ₹174.79 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.94 | 99.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 44.00 | 48.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.48 | 1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.22 | ₹10.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.69 | 99.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Admach Systems IPO Retail Individual Investors (RII) are offered 7,21,200 shares while in Bio Medica Laboratories IPO retail investors are offered 7,21,200 shares. Qualified Institutional Buyers (QIB) are offered 3,81,600 shares in Admach Systems IPO and 36,000 shares in Bio Medica Laboratories IPO.
| Admach Systems IPO | Bio Medica Laboratories IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,10,600 shares | 0 shares |
| Market Maker Reservation | 89,400 shares | 1,89,000 shares |
| QIB | 3,81,600 shares | 36,000 shares |
| NII | 3,79,800 shares | 17,55,000 shares |
| RII | 7,21,200 shares | 17,92,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 16,93,200 shares | 35,83,000 shares |
Admach Systems IPO subscribed 3.61x in total, whereas Bio Medica Laboratories IPO subscribed 2.26x.
| Admach Systems IPO | Bio Medica Laboratories IPO | |
|---|---|---|
| QIB (times) | 1.55x | 15.94x |
| NII (times) | 7.40x | 1.30x |
| Big NII (times) | 9.21x | 0.86x |
| Small NII (times) | 3.76x | 2.19x |
| RII (times) | 3.77x | 2.92x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.61x | 2.26x |
